Loading
Conferences headline the trials that worked, while most negative trials end up as posters or are never submitted. A standing plenary at ASCO, ESMO and AACR for negative and practice-reversing trials, with a discussant drawing lessons for design and biology, would make the failures impossible to miss.
Practice-changing negative trials (for example those that stop an established practice) are sometimes presented, but most negative trials are relegated to posters or never submitted. A standing plenary session at ASCO, ESMO and AACR for high-importance negative and reversal trials, with a discussant focused on lessons for design and biology, would raise the status of reporting failure.
Shares European Society for Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO), Failures are hidden, Knowledge reaches practice too slowly.
Shares European Society for Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO), Knowledge reaches practice too slowly.
Shares European Society for Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO), Knowledge reaches practice too slowly.
Shares Compliance with results reporting at ClinicalTrials.gov, Failures are hidden.
Shares Compliance with results reporting at ClinicalTrials.gov, Failures are hidden, Knowledge reaches practice too slowly.
Shares European Society for Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO), Knowledge reaches practice too slowly.
Shares European Society for Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO), Knowledge reaches practice too slowly.
Shares Compliance with results reporting at ClinicalTrials.gov, Failures are hidden.